🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "targeted action to address cost of living issues" in the forthcoming financial statement.

During an interview with media outlets, she emphasized that curbing inflation is a collective task of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the G7 advanced economies this year and the following year.

Possible Energy Cost Interventions

It is understood the administration could intervene to reduce utility costs, such as by slashing the present 5% level of value-added tax charged on energy.

A further approach is to lower some of the regulatory levies currently added to household expenses.

Fiscal Constraints and Analyst Expectations

The administration will receive the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much scope there is for such measures.

The view from most economists is that the Chancellor will have to introduce tax increases or budget cuts in order to meet her self-imposed debt limits.

Earlier on Thursday, calculations suggested there was a £22bn shortfall for the Treasury chief to address, which is at the more modest range of expectations.

"It is a shared task between the central bank and the administration to continue tackling some of the causes of price increases," the Chancellor stated to reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Commitments and Global Concerns

While much of the focus has been on likely tax rises, the chancellor said the most recent data from the fiscal watchdog had not altered her pledge to manifesto promises not to raise tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and trade tensions for the fiscal tax moves, probably to be focused on those "with the broadest shoulders."

International Economic Tensions

Addressing worries about the UK's economic relations with China she said: "Our security interests invariably come first."

Recent announcement by China to increase export controls on rare earths and other materials that are essential for high-technology production led US President Donald Trump to threaten an further 100% tariff on goods from China, raising the possibility of an full-scale commercial conflict between the two largest economies.

The American finance chief called China's move "commercial pressure" and "a international production power grab."

Asked about accepting the American proposal to join its conflict with China, the Chancellor said she was "extremely troubled" by China's measures and called on the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the world economy and causes additional headwinds."

"In my view there are fields where we should challenge China, but there are also important opportunities to export to China's economy, including financial services and other areas of the economy. We've got to maintain that balance right."

The Treasury chief also stated she was cooperating with international partners "regarding our own essential resources strategy, so that we are more independent."

NHS Drug Costs and Investment

The Chancellor also acknowledged that the cost the NHS pays for drugs could rise as a result of ongoing negotiations with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the world's largest drug companies have said recently that they are either pausing or abandoning projects in the UK, with several blaming the insufficient payments they are obtaining.

Last month, the Science Minister said the cost the health service pays for drugs would need to rise to halt businesses and drug research funding leaving the United Kingdom.

Reeves stated to media: "We have seen as a result of the payment system, that clinical trials, innovative medicines have not been offered in the United Kingdom in the extent that they are in other European countries."

"We want to ensure that individuals receiving treatment from the National Health Service are able to access the top critical drugs in the globe. And so we are looking at these issues, and... aiming to secure increased investment into the UK."